Calendar Replimune Group, Inc.

Equities

REPL

US76029N1063

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 13/06/2025 BST			5-day change	1st Jan Change
9.780 ^USD	-1.06%		-5.78%	-19.24%

06-01	Replimune Presents New Analyses From The IGNYTE Study Of RP1 Plus Nivolumab In Anti-PD1 Failed Melanoma At The 2025 American Society Of Clinical Oncology (ASCO) Annual Meeting	RE
06-01	Replimune Group, Inc. Presents New Analyses from the Ignyte Study of Rp1 Plus Nivolumab in Anti-Pd-1 Failure Melanoma At the 2025 American Society of Clinical Oncology Annual Meeting	CI

Chart calendar Replimune Group, Inc.

fea67c1ee3f4079c4061011a78.uQMG1vRFfxEWAXUSf4xEMD8-7-KUi5rb7R_3YaGN5Fc._nlHtLwaT0M7eyxfM9R9XWwGo9vZw-69vEu0DPnklxjpTUu7nxIJdXI5IA~2f923d423b5a6600a92212ca3dd2b69c

Upcoming events on Replimune Group, Inc.

24/06/2025 13:00	Investor Day
30/07/2025	Q1 2026 Earnings Release (Projected)
29/10/2025	Q2 2026 Earnings Release (Projected)
13/05/2026	Q4 2026 Earnings Release (Projected)
29/07/2026	Q1 2027 Earnings Release (Projected)

Past events on Replimune Group, Inc.

05/06/2025 21:20	Jefferies Healthcare Conference
01/06/2025 15:00	American Society of Clinical Oncology Meeting - Abstract No 9537
22/05/2025 13:00	Q4 2025 Earnings Call
22/05/2025 12:00	Q4 2025 Earnings Release
13/01/2025 22:15	JP Morgan Healthcare Conference
12/11/2024 13:00	Q2 2025 Earnings Release
09/11/2024 17:45	Society for Immunotherapy of Cancer Meeting - Abstract No: 1504
07/11/2024	Society for Immunotherapy of Cancer Meeting - Abstract No: 693
08/10/2024	Roth Healthcare Opportunities Conference
07/10/2024	BMO Oncology Summit
15/09/2024 14:45	European Society for Medical Oncology Meeting
04/09/2024 20:00	Annual General Meeting
12/08/2024	Wedbush PacGrow Healthcare Conference
08/08/2024 13:00	Q1 2025 Earnings Release
04/08/2024	BTIG Virtual Biotechnology Conference
11/06/2024 19:00	Goldman Sachs Global Healthcare Conference
06/06/2024 13:00	IGNYTE Clinical Trial Update Call
03/06/2024 16:57	American Society of Clinical Oncology Meeting - Abstract #9517
03/06/2024 15:57	American Society of Clinical Oncology Meeting - Abstract #9511
01/06/2024 19:30	American Society of Clinical Oncology Meeting - Abstract #TPS9614

Annual results

Fiscal Period	March	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 2,01 -	56,1	155	278
EBITDA Million USD	Released Forecast Spread	-175 -176 0.78%	0,00 0,00 -	-265 -263 -0.75%	-240	0,00	0,00
EBIT Million USD	Released Forecast Spread	-177 -169 -4.69%	-235 -230 -1.92%	-262 -253 -3.35%	-286	-236	-140
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-174 -169 -2.66%	-215 -217 0.74%	-247 -247 0.24%	-269	-238	-126
Net income Million USD	Released Forecast Spread	-174 -169 -2.85%	-216 -217 0.69%	-247 -245 -1.02%	-263	-212	-126
EPS USD	Released Forecast Spread	-2,99 -2,91 -2.78%	-3,24 -3,23 -0.31%	-3,07 -3,06 -0.42%	-2,97	-2,15	-1,25
Announcement Date		18/05/23	16/05/24	22/05/25	-

Quarterly results

Fiscal Period	March	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	1,58	6,95	15,4	27,3	29,9	38,3	46,8	52,6
EBIT Million USD	Released Forecast Spread	-63,8 -57,1 -11.84%	-56,5 -64,3 12.11%	-58,8 -56,1 -4.8%	-57,4 -62,3 7.87%	-58,9 -58,2 -1.26%	-66,0 -60,0 -10.12%	-79,3 -67,2 -18.05%	-78,4	-76,8	-70,7	-57,8	-52,5	-45,9	-39,7	-36,5
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-60,2 -55,8 -7.98%	-50,6 -60,6 16.43%	-55,1 -52,9 -4.17%	-53,8 -60,4 10.98%	-53,1 -54,5 2.6%	-65,8 -56,9 -15.66%	-74,2 -65,9 -12.69%	-75,5	-71,3	-60,9	-52,5	-49,1	-42,5	-36,3	-33,1
Net income Million USD	Released Forecast Spread	-60,0 -54,6 -9.97%	-51,1 -61,7 17.11%	-55,1 -53,6 -2.78%	-53,8 -59,6 9.85%	-53,1 -54,5 2.61%	-66,3 -56,6 -17.26%	-74,1 -64,9 -14.13%	-71,6	-66,8	-60,1	-54,7	-49,1	-42,5	-36,3	-33,1
EPS USD	Released Forecast Spread	-0,90 -0,86 -4.48%	-0,77 -0,94 17.77%	-0,25 -0,80 68.91%	-0,78 -0,87 10.13%	-0,68 -0,77 11.14%	-0,79 -0,72 -9.63%	-0,82 -0,75 -8.95%	-0,84	-0,81	-0,76	-0,68	-0,46	-0,39	-0,34	-0,30
Announcement Date		07/11/23	08/02/24	16/05/24	08/08/24	12/11/24	12/02/25	22/05/25	-	-	-	-	-	-	-	-

Upcoming sector events for Replimune Group, Inc.

15/06/2025	MIRAI CORPORATION: Q2 2025 Earnings Release
15/06/2025	AÉROPORTS DE PARIS: May 2025 Sales and Revenue Release - Traffic Figures
15/06/2025	LENNAR CORPORATION: Q2 2025 Earnings Release
15/06/2025	RENEW ENERGY GLOBAL PLC: Q4 2025 Earnings Release
15/06/2025	PARK24 CO., LTD.: Q2 2025 Earnings Release
15/06/2025	POWERFLEET INC.: Q4 2025 Earnings Release
15/06/2025	NTT UD REIT INVESTMENT CORPORATION: Q2 2025 Earnings Release
15/06/2025	CAFÉ DE CORAL HOLDINGS LIMITED: Q4 2025 Earnings Release
15/06/2025	ICHIGO OFFICE REIT INVESTMENT CORPORATION: Q2 2025 Earnings Release
16/06/2025 07:00	NEXTENERGY SOLAR FUND LIMITED: Q4 2025 Earnings Release

More events

Past sector events for Replimune Group, Inc.

13/06/2025 22:22	FREEDOM HOLDING CORP.: Q4 2025 Earnings Release
13/06/2025 13:45	CHARLES SCHWAB: May 2025 Sales and Revenue Release - Activities Report
13/06/2025 12:02	UTILICO EMERGING MARKETS TRUST PLC: Q4 2025 Earnings Release
13/06/2025 07:00	OXFORD INSTRUMENTS PLC: Q4 2025 Earnings Release
13/06/2025 07:00	AVI GLOBAL TRUST PLC: Q2 2025 Earnings Release
13/06/2025 06:00	FRAPORT AG: May 2025 Sales and Revenue Release - Traffic Figures
12/06/2025	ASTROSCALE HOLDINGS INC.: Q4 2024 Earnings Release
12/06/2025	KURA SUSHI,INC.: Q2 2025 Earnings Release
12/06/2025	H.I.S. CO., LTD.: Q2 2025 Earnings Release
12/06/2025	J.S.B.CO.,LTD.: Q2 2025 Earnings Release